文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

神经退行性疾病的动物模型。

Animal models of neurodegenerative diseases.

机构信息

Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Department of Neurology; and Department of Pharmacology and Molecular Sciences, Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA, USA.

出版信息

Nat Neurosci. 2018 Oct;21(10):1370-1379. doi: 10.1038/s41593-018-0236-8. Epub 2018 Sep 24.


DOI:10.1038/s41593-018-0236-8
PMID:30250265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6615039/
Abstract

Animal models of adult-onset neurodegenerative diseases have enhanced the understanding of the molecular pathogenesis of Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Nevertheless, our understanding of these disorders and the development of mechanistically designed therapeutics can still benefit from more rigorous use of the models and from generation of animals that more faithfully recapitulate human disease. Here we review the current state of rodent models for Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. We discuss the limitations and utility of current models, issues regarding translatability, and future directions for developing animal models of these human disorders.

摘要

动物模型在成人发病的神经退行性疾病的研究中发挥了重要作用,增进了我们对阿尔茨海默病、帕金森病、额颞叶痴呆和肌萎缩侧索硬化症等疾病的分子发病机制的理解。然而,我们对这些疾病的认识以及针对这些疾病的机制设计疗法的开发仍然可以从更严格地使用这些模型以及从更忠实地再现人类疾病的动物的产生中受益。在这里,我们回顾了用于阿尔茨海默病、帕金森病、额颞叶痴呆和肌萎缩侧索硬化症的啮齿动物模型的现状。我们讨论了当前模型的局限性和实用性、转化问题以及开发这些人类疾病动物模型的未来方向。

相似文献

[1]
Animal models of neurodegenerative diseases.

Nat Neurosci. 2018-9-24

[2]
Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.

Neural Regen Res. 2022-7

[3]
Genetically modified pig models for neurodegenerative disorders.

J Pathol. 2016-1

[4]
Dendritic Spine Pathology in Neurodegenerative Diseases.

Annu Rev Pathol. 2016-2-22

[5]
Anhedonia in Neurodegenerative Diseases.

Curr Top Behav Neurosci. 2022

[6]
Correlation between C9ORF72 mutation and neurodegenerative diseases: A comprehensive review of the literature.

Int J Med Sci. 2021

[7]
Human Endogenous Retroviruses in Neurodegenerative Diseases.

Genes (Basel). 2024-6-5

[8]
miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.

J Alzheimers Dis. 2015

[9]
The genetic overlap between Alzheimer's disease, amyotrophic lateral sclerosis, Lewy body dementia, and Parkinson's disease.

Neurobiol Aging. 2023-7

[10]
Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.

Stem Cell Rev Rep. 2022-2

引用本文的文献

[1]
Research hotspots and trends in the interaction mechanisms of neuroinflammation and sleep disorders: A bibliometric analysis based on WOS.

IBRO Neurosci Rep. 2025-8-15

[2]
Advancement in modeling of Alzheimer's disease: a comprehensive review of preclinical screening platforms.

Front Aging Neurosci. 2025-8-6

[3]
Advancing precision medicine therapeutics for Parkinson's utilizing a shared quantitative systems pharmacology model and framework.

Front Syst Biol. 2024-3-8

[4]
Multi-coil TMS for preclinical applications in ultra-high-field MRI.

Imaging Neurosci (Camb). 2025-5-2

[5]
Divergent and convergent TMEM106B pathology in murine models of neurodegeneration and human disease.

Acta Neuropathol Commun. 2025-8-9

[6]
The Beneficial Effects of Berberine on Brain Functions in Age-Related Neurological Disorders: From Molecular Signaling to Treatment.

Food Sci Nutr. 2025-8-1

[7]
Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders.

Curr Issues Mol Biol. 2025-6-4

[8]
Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions.

Mol Neurodegener. 2025-7-10

[9]
Investigational Gene Therapies for Parkinson's Disease.

CNS Drugs. 2025-7-10

[10]
3D culture of neural progenitor cells in gelatin norbornene (GelNB) hydrogels: mechanical tuning and hypoxia characterization.

Front Bioeng Biotechnol. 2025-5-30

本文引用的文献

[1]
Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.

Nat Med. 2018-6-25

[2]
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.

Nat Med. 2018-6-11

[3]
Mouse models of ALS: Past, present and future.

Brain Res. 2018-8-15

[4]
TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD.

Nat Neurosci. 2018-3-19

[5]
Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.

Development. 2018-3-8

[6]
Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.

Genome Med. 2018-2-26

[7]
The genetic landscape of Alzheimer disease.

Handb Clin Neurol. 2018

[8]
Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy.

Nat Neurosci. 2018-3

[9]
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.

Nat Med. 2018-2-5

[10]
Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice.

Proc Natl Acad Sci U S A. 2018-1-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索